Srikanth Nagalla, MD

Director, Clinical Hematology
Miami Cancer Institute

Poster(s):

• (359) Healthcare Resource Utilization in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: REAL-AVA 2.0 Study Results
  Wednesday, October 29, 2025